Evidence for a role for MMR in neurodegenerative disease in humans has emerged from genome-wide association studies (GWAS) in HD patients wherein MSH3, PMS1, PMS2, and MLH1 have been identified as modifiers of disease onset age (10, , , , , –16). Here, PMS2 is linked to Huntington disease.